Neuronetics Inc at Piper Sandler Healthcare Conference Transcript

Dec 01, 2022 / 02:30PM GMT
Adam Maeder - Piper Sandler - Analyst

Good morning. Welcome to the 2022 Piper Sandler healthcare conference. My name is Adam Maeder. I'm one of the medtech research analysts here at Piper. Very pleased to introduce the management team from Neuronetics. With us, we have Keith Sullivan, the President and CEO; Steve Furlong, SVP, CFO, and Treasurer. Gentlemen, thanks so much for coming.

Keith Sullivan - Neuronetics, Inc. - President & CEO

Thanks, Adam.

Questions and Answers:

Adam Maeder - Piper Sandler - Analyst

Nice to see you. So maybe a good place to start is with the Q3 results. You're coming up a nice Q3 print, good performance both in terms of system placements and session volumes. You took up the full-year outlook. Maybe just spend some time on the expectations for 4Q. How do we think about the mix of capital and treatment sessions? And what's maybe assumed in some of the guidance for macro headwinds, et cetera?

Steve Furlong - Neuronetics, Inc. - SVP, CFO, & Treasurer<
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot